Company Filing History:
1 out of 71 
1 out of 92 
Years Active: 2017
Title: The Innovative Mind of Maurice P. DeYoung
Introduction: Maurice P. DeYoung is a prominent inventor based in Collegeville, PA, recognized for her contributions to cancer treatment through innovative methods. With a keen focus on developing therapies for mesothelioma, her work has significantly impacted the field of oncology.
Latest Patents: Maurice P. DeYoung holds one notable patent titled "Methods of treating mesothelioma by administration of compounds comprising FGFR1 ECD." This invention involves methods of treating cancers using fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or FGFR1 ECD fusion molecules. Additionally, it outlines the combination of these compounds with at least one anti-angiogenic agent to enhance treatment efficacy.
Career Highlights: Throughout her career, Maurice has made significant strides in the medical and pharmaceutical industries. She has been associated with leading companies such as Five Prime Therapeutics, Inc. and GlaxoSmithKline Intellectual Property Limited, where she focused on research and development related to innovative cancer therapies.
Collaborations: Maurice’s journey has been marked by collaborations with esteemed colleagues such as David Bellovin and Kevin P. Baker, furthering the reach and impact of her work in cancer treatment methodologies. These collaborations highlight the importance of teamwork and collective effort in innovation.
Conclusion: Maurice P. DeYoung’s dedication to advancing cancer treatments through her patented methods signifies her role as a groundbreaking inventor in the medical field. Her work not only showcases innovation but also provides hope to patients battling mesothelioma and other related cancers. Her contributions continue to inspire future advancements in cancer research and treatment.